Literature DB >> 23649954

Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.

Soraya A Berti-Couto1, Ana Carolina U Vasconcelos, Júlia E Iglesias, Maria Antonia Z Figueiredo, Fernanda G Salum, Karen Cherubini.   

Abstract

BACKGROUND: The purpose of this study was to investigate the influence of diabetes and corticotherapy on the development of osteonecrosis of the jaws associated with sodium alendronate.
METHODS: Rats were allocated into 4 groups of 11 animals each, representing different treatments: (1) alendronate; (2) alendronate and corticotherapy; (3) alendronate and diabetes; and (4) control. Tooth extractions were performed in all animals, and histological analysis was performed by hematoxylin and eosin staining and immunohistochemistry using anti-bone morphogenetic protein (BMP)-4 and anti-matrix metalloproteinase (MMP)-13 antibodies.
RESULTS: On hematoxylin and eosin analysis, proportions of inflammatory infiltrate, microbial colonies, and osteonecrosis were significantly greater in the diabetes group. BMP-4 expression in connective tissue was higher in the corticosteroid group than the alendronate group. There were no significant differences between the other groups. MMP-13 expression did not differ between the groups analyzed.
CONCLUSION: Diabetes but not corticotherapy is associated with jaw osteonecrosis in rats undergoing alendronate therapy and subjected to tooth extractions.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  alendronate; bisphosphonate-related osteonecrosis of the jaw (BRONJ); bisphosphonates; corticotherapy; diabetes mellitus

Mesh:

Substances:

Year:  2013        PMID: 23649954     DOI: 10.1002/hed.23260

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.

Authors:  Qunzhou Zhang; Weihua Yu; Sumin Lee; Qilin Xu; Ali Naji; Anh D Le
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

Review 2.  Diabetes as a risk factor for medication-related osteonecrosis of the jaw.

Authors:  A Peer; M Khamaisi
Journal:  J Dent Res       Date:  2014-12-04       Impact factor: 6.116

3.  Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis.

Authors:  Miguel Luciano Silva; Leandro Tasso; Alan Arrieira Azambuja; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Vinicius Duval da Silva; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

4.  Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.

Authors:  Tomoya Soma; Ryotaro Iwasaki; Yuiko Sato; Tami Kobayashi; Satoshi Nakamura; Yosuke Kaneko; Eri Ito; Hiroyuki Okada; Hisato Watanabe; Kana Miyamoto; Morio Matsumoto; Masaya Nakamura; Seiji Asoda; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2020-11-17       Impact factor: 2.626

5.  Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.

Authors:  Valesca Sander Koth; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2020-09-23       Impact factor: 3.573

Review 6.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

7.  Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts.

Authors:  Yuko Komatsu; Miho Ibi; Naoyuki Chosa; Seiko Kyakumoto; Masaharu Kamo; Toshiyuki Shibata; Yoshiki Sugiyama; Akira Ishisaki
Journal:  Int J Mol Med       Date:  2016-05-10       Impact factor: 4.101

8.  Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw.

Authors:  Seung Jae Paek; Won-Jong Park; Ho-Sung Shin; Moon-Gi Choi; Kyung-Hwan Kwon; Eun Joo Choi
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-10-25

9.  Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.

Authors:  X Vidal-Gutiérrez; J-F Gómez-Clavel; L-A Gaitán-Cepeda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-03-01

Review 10.  Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.

Authors:  Henrik Holtmann; Julian Lommen; Norbert R Kübler; Christoph Sproll; Majeed Rana; Patrick Karschuck; Rita Depprich
Journal:  J Int Med Res       Date:  2018-08-09       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.